Editas Medicine (EDIT) Insider Trading & Ownership → 8,788% Return Predicted For THIS Crypto (already up 40% in 6 months) (From Paradigm Press) (Ad) Free EDIT Stock Alerts $7.72 -0.41 (-5.04%) (As of 03/18/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Editas Medicine (NASDAQ:EDIT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.20%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$1.05 M Get EDIT Insider Trade Alerts Want to know when executives and insiders are buying or selling Editas Medicine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EDIT Insider Buying and Selling by Quarter Ad InvestorPlaceThey said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.There are five coins you must take a look at right away. Editas Medicine Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/5/2024Gilmore Neil O'neillCEOSell77,824$9.42$733,102.08 3/4/2024Baisong MeiSVPSell20,327$9.42$191,480.34 12/5/2023Bruce EatonEVPSell103$10.90$1,122.70 11/7/2023Bruce EatonEVPSell139$8.40$1,167.60 9/6/2023Bruce EatonEVPSell103$8.82$908.46 8/11/2023Bruce EatonEVPSell702$8.59$6,030.18 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/8/2023Bruce EatonEVPSell141$8.39$1,182.99 7/19/2023Baisong MeiSVPSell4,317$8.80$37,989.60 6/5/2023Bruce EatonEVPSell105$9.50$997.50 6/5/2023Gilmore Neil O'neillCEOSell6,486$9.50$61,617.00 5/11/2023Bruce EatonEVPSell668$9.87$6,593.16 5/11/2023Michelle RobertsonCFOSell949$9.87$9,366.63 5/9/2023Bruce EatonEVPSell135$9.51$1,283.85 (Data available from 1/1/2013 forward) EDIT Insider Trading Activity - Frequently Asked Questions Who is on Editas Medicine's Insider Roster? The list of insiders at Editas Medicine includes Baisong Mei, Bruce Eaton, Gilmore Neil O'neill, James C Mullen, Lisa Anne Michaels, Mark S Shearman, and Michelle Robertson. Learn more on insiders at EDIT. What percentage of Editas Medicine stock is owned by insiders? 2.20% of Editas Medicine stock is owned by insiders. Learn more on EDIT's insider holdings. Which Editas Medicine insiders have been selling company stock? The following insiders have sold EDIT shares in the last 24 months: Baisong Mei ($229,469.94), Bruce Eaton ($68,769.92), Gilmore Neil O'neill ($794,719.08), Mark S Shearman ($78,738.00), and Michelle Robertson ($84,375.58). How much insider selling is happening at Editas Medicine? Insiders have sold a total of 131,098 Editas Medicine shares in the last 24 months for a total of $1,256,072.52 sold. Which members of congress are trading Editas Medicine? Daniel S. Goldman (D-NY) has sold shares of Editas Medicine in the last year totaling $8,000. More Insider Trading Tools from MarketBeat Related Companies: NVAX Insider Ownership FUSN Insider Ownership CGEM Insider Ownership CCCC Insider Ownership FATE Insider Ownership ALLO Insider Ownership ALEC Insider Ownership HLVX Insider Ownership REPL Insider Ownership CABA Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insider Selling of Amazon Spikes in Q1, but it's Not Time to Sell3 Small Dividend Paying Banks Insiders are Buying3 Stocks Insiders are Buying at New HighsInsider selling at JPM: A Closer Look Amidst Historic CEO Sale2 penny stocks insiders are buying This page (NASDAQ:EDIT) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Editas Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.